The Howard Hughes Medical Institute  by unknown
Magazine 107
Gazetteer
The Howard Hughes
Medical Institute
What is it famous for? Distributing
the legacy of Howard Hughes to
medical researchers.
How did it start? Hughes apparently
had the idea as early as 1925, but
nothing actually happened until he
had an accident in an experimental
plane in 1946 — Verne Mason, a
professor of clinical medicine at the
University of Southern California,
took personal charge of his
convalescence and talked to him at
length about medical research. The
institute was chartered in 1953.
Where did the money come from?
Hughes inherited a company that
made tools in 1924, and quickly
started a company making planes.
The Hughes Aircraft Company was
sold for $5 billion in 1985. 
What’s the best thing about HHMI
funding? There's lots of it. The annual
HHMI budget was $330 million in
1994, of which about 80 % was spent
on the 227 HHMI investigators. For
those who need lots of money for mice
or equipment, HHMI funding can be
the answer to a prayer. And HHMI,
unlike most other funding bodies,
does not discourage long-term, risky
research or projects with little obvious
relevance to practical problems.
What's the worst thing about HHMI
funding? It makes it very hard to
move. HHMI often puts a lot of
money into refurbishing laboratory
space for its investigators, so generally
won't agree to do it all again without
good reason. Portable HHMI funding
would probably lead to intense
competition between universities for
those who are already funded. The
Institute is also sometimes said to
micromanage its investigators, laying
down the law about tiny details such
as where they can buy supplies.
How do they decide who becomes an
HHMI investigator? Periodically,
HHMI invites institutions to
nominate investigators to be funded.
In 1994, 285 were nominated, and 44
selected. The next request for
nominations looks likely to go out
towards the end of 1996.
Biology in pictures
Art meets science?
The picture below, Apotryptophanase,
is one of the ‘spot’ paintings by
Damien Hirst, 1995 winner of the
prestigious £20,000 Turner prize
(awarded to “a British artist under 50
for an outstanding exhibition ...”). 
Hirst’s work has long been
controversial, particularly among
animal lovers: he is best known in
Britain for an exhibit of a sheep
pickled in formaldehyde that was
sabotaged by the addition of a large
volume of black ink. The Turner
prize-winning exhibit was Mother and
Child Divided, a cow and calf bisected
longitudinally and presented in two
halves, but also on display were two
of his spot paintings, described by
the Tate Gallery that hosted the
exhibition as “white canvasses
covered in a slightly irregular grid of
coloured circles.” 
According to an associate, Hirst’s
aim with this series of paintings is to
represent the pills so prevalent in
modern Western society, so he takes
their names at random from a
pharmacopoeia; at the moment he is
in the ‘A’ section. Hirst’s aim will be
met only partially, at best, for the
scientists in his audience. Within the
spot series, neither Asialoglycophorin
(a protein of the red blood cell’s
membrane, lacking a sialic acid
moiety) nor Apotryptophanase (an
enzyme) is strictly pharmacological;
Apomorphine is doubtless closer to
what Hirst had in mind. 
